The global blood transfusion diagnostics market is witnessing steady expansion as blood typing and blood screening remain essential before transfusion procedures. Blood transfusion diagnostics support the identification of blood types and the detection of diseases and infections that could cause adverse effects or transmission of infection. Increasing requirements for safe blood transfusion practices across healthcare settings are supporting the development of the market. North America represented the leading regional market in 2021, accounting for 41.8 percent of the global blood transfusion diagnostics market. The region benefits from demand associated with surgical procedures, blood transfusion management, and developments in healthcare systems.
According to The Insight Partners, the Blood Transfusion Diagnostics Market is expected to grow from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. The market is estimated to register a CAGR of 6.9 percent from 2022 to 2028. This increase in market size reflects the continuing need for diagnostic testing before blood and blood components are transfused into patients. The report evaluates the market across product, application, end user, and geographic segments while providing insights into market dynamics and the competitive landscape.
Download Sample PDF:
https://www.theinsightpartners.com/sample/TIPRE00005176
Blood Transfusion Diagnostics Market Size and Growth:
The blood transfusion diagnostics market size is projected to increase significantly during the forecast period. The market valuation of US$ 4,096.93 million in 2021 is expected to reach US$ 6,483.75 million by 2028. The projected CAGR of 6.9 percent from 2022 to 2028 indicates sustained market expansion over the forecast period.
Blood transfusion diagnostics include tests conducted on blood and blood components before transfusion. Each unit of donated blood undergoes blood typing and blood screening. These procedures are important for identifying blood types and detecting diseases and infections. The market therefore plays an important role in supporting blood transfusion safety across healthcare facilities.
Key Factors Supporting Market Expansion:
One of the significant factors supporting the blood transfusion diagnostics market is the rising need for blood transfusions associated with organ transplant surgeries. Organ transplantation procedures can involve substantial blood loss and consequently increase the requirement for blood transfusion. The increasing number of organ transplant procedures across developed and developing countries is contributing to demand for blood transfusion diagnostics.
The rapid increase in chronic diseases is another factor associated with overall market growth. Chronic conditions can contribute to the need for surgical procedures and treatments where blood transfusion may be required. As healthcare systems expand their capabilities for managing complex medical procedures, the need for reliable blood screening and blood grouping continues to support market development.
Product Segment Analysis:
Based on product, the blood transfusion diagnostics market is divided into instruments and kits and reagents. The instruments and kits segment accounted for the larger market share in 2021 and is expected to register a higher CAGR during the forecast period. The continued use of instruments and kits for blood screening and blood grouping makes this segment an important component of the overall market. Their role in supporting diagnostic procedures before transfusion contributes to the segment’s market position.
Application Segment Analysis:
By application, the blood transfusion diagnostics market is categorized into disease screening and blood grouping. Disease screening held the larger market share in 2021 and is expected to register the higher CAGR during the forecast period. Disease screening is an important part of blood transfusion diagnostics because donated blood must be evaluated for diseases and infections before transfusion. Blood screening supports the identification of conditions that could otherwise result in infection transmission or adverse effects.
End User Segment Analysis:
The market is segmented by end user into blood banks, hospitals, diagnostic laboratories, and plasma fractionation companies. Blood banks accounted for the largest market share in 2021, representing 40.2 percent of the market, and the segment is expected to register the highest CAGR from 2022 to 2028. Blood banks have a central role in the collection, screening, grouping, and management of donated blood. Their continued requirement for diagnostic procedures supports their position within the blood transfusion diagnostics market.
Buy Premium Report: https://www.theinsightpartners.com/buy/TIPRE00005176
Regional Market Insights:
North America dominated the global blood transfusion diagnostics market in 2021 with a 41.8 percent share. The United States is the largest market within the region, and the US market is projected to grow at a CAGR of 7.4 percent during the forecast period.
Asia Pacific is another important growth region and is expected to register a CAGR of 7.9 percent during the forecast period. Improvements in blood transfusion management, the prevalence of conditions such as sepsis and thalassemia, and the introduction of advanced molecular platforms are identified as factors supporting regional growth. The global market is also segmented into Europe, the Middle East and Africa, and South and Central America, providing a broad geographic scope for assessing market development.
Top Key Players:
The blood transfusion diagnostics market includes several established companies operating across diagnostic products and technologies. Key players identified in the report include:
- Grifols SA
- F Hoffmann La Roche Ltd
- Immucor Inc
- Bio Rad Laboratories Inc
- Abbott
- Thermo Fisher Scientific Inc
- Ortho Clinical Diagnostics
- DiaSorin SpA
- Quotient Limited
- BAG Diagnostics GmbH
These companies are analyzed in relation to their market presence, products, competitive positioning, and strategic developments.
Future Outlook:
The future outlook for the blood transfusion diagnostics market remains positive, with the market expected to expand from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. The 6.9 percent CAGR projected for 2022 to 2028 reflects continued demand for blood typing and screening procedures.
Increasing requirements associated with organ transplantation, chronic diseases, surgical procedures, and blood transfusion management are expected to remain important factors influencing market development. At the same time, growth in Asia Pacific and continued market activity in North America are contributing to the broader expansion of the global blood transfusion diagnostics market.
As healthcare providers and blood banks continue to rely on diagnostic procedures before transfusion, blood transfusion diagnostics are expected to remain an important component of safe and effective blood management. The combination of market expansion, disease screening requirements, and advancements in diagnostic platforms provides a positive foundation for the market through 2028.
Trending Reports:
- Dental Prosthetic & Implant Consumables Market Demand, Size & Forecast by 2034
- Prosthetic Liners Market Size, Growth & Demand by 2034
About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in:
Korean|German|Japanese|French|Chinese|Italian|Spanish
